Strategic partnership Spaulding Rehab collaborates with external pharma and rehabilitation centers (e.g., Neuro-Innovators) to advance neuroplasticity therapies, signaling a potential sales avenue for partnerships in clinical research, trials support, and distribution of neurorehabilitation products.

Top-tier reputation Consistent recognition as a top rehabilitation hospital by US News & World Report enhances credibility for value-based purchasing, contract opportunities, and preferred provider arrangements with payors and large health systems.

Tech-enabled care Existing tech stack includes Meditech and Omnicell, with web and analytics capabilities via WordPress and Facebook Pixel, indicating openness to integrated health IT solutions, patient engagement platforms, and supply chain optimization tools.

Growth and scale With revenue in the hundreds of millions and a sizable employee base, Spaulding Rehab represents a mid-to-large market opportunity for enterprise software, medical devices, and services designed for hospital networks and rehabilitation services.

Network leverage As part of a renowned network within Mass General Brigham and Harvard Medical School affiliations, there are opportunities to pitch innovative clinical programs, remote monitoring, adaptive sports programs, and nationwide or systemwide program rollouts.